Substituted heteroaryl compounds and methods of use
US10266521B2 · kind B2 · utility
0Cited by
29References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 4, 2018 |
| Grant date | Apr 23, 2019 |
| Priority date | — |
| Expiry date | Jan 4, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel heteroaryl compounds, pharmaceutical acceptable salts and formulations thereof. They are useful in preventing, managing, treating or lessening the severity of a protein kinase-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of protein kinase-mediated disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.